Traverso Chambers Private Wealth Management, LLC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 206 filers reported holding MYRIAD GENETICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
Traverso Chambers Private Wealth Management, LLC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$166,126
-30.8%
10,3570.0%0.04%
-30.2%
Q2 2023$240,075
-0.2%
10,3570.0%0.06%
-4.5%
Q1 2023$240,593
+60.1%
10,3570.0%0.07%
+53.5%
Q4 2022$150,280
-24.1%
10,3570.0%0.04%
-29.5%
Q3 2022$198,000
+5.3%
10,3570.0%0.06%
-3.2%
Q2 2022$188,000
-28.0%
10,3570.0%0.06%
-19.2%
Q1 2022$261,000
-8.7%
10,3570.0%0.08%
-8.2%
Q4 2021$286,000
-14.4%
10,3570.0%0.08%
-18.3%
Q3 2021$334,000
+5.4%
10,3570.0%0.10%
+4.0%
Q2 2021$317,000
+0.6%
10,3570.0%0.10%
-5.7%
Q1 2021$315,000
-5.4%
10,357
-38.6%
0.11%
-11.7%
Q4 2020$333,000
+51.4%
16,8570.0%0.12%
+41.2%
Q3 2020$220,000
+15.2%
16,8570.0%0.08%
+6.2%
Q2 2020$191,000
-20.7%
16,8570.0%0.08%
-29.8%
Q1 2020$241,000
-25.4%
16,857
+42.2%
0.11%
-16.8%
Q4 2019$323,00011,8570.14%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$90,850,0003.94%
Altium Capital Management LP 221,000$4,016,0001.61%
DISCIPLINED GROWTH INVESTORS INC /MN 1,900,787$34,537,0000.93%
Zebra Capital Management LLC 15,352$279,0000.82%
PFM Health Sciences, LP 1,177,250$21,391,0000.82%
EARNEST PARTNERS LLC 6,462,138$117,417,0000.78%
Glenview Capital Management 1,696,791$30,831,0000.77%
AIMZ Investment Advisors, LLC 42,085$765,0000.37%
Phocas Financial Corp. 127,949$2,325,0000.35%
Redhawk Wealth Advisors, Inc. 34,680$630,0000.29%
View complete list of MYRIAD GENETICS INC shareholders